152,0,152
2086842496,Dermatomyositis: Modern Diagnostic Paradigms
2086756096,The HTLV-1 Neurological Complex: Beyond Myelopathy
2086669696,Alpha-Lipoic Acid Efficacy in ... Polyneuropathy Symptoms
2086583296,Etiological Screening Strategies for Small Fiber Neuropathy
2086237696,Tenecteplase in acute central retinal ... Clinical Trial
2086151296,How to use blood-based biomarkers to ... disease
2085978496,Brief Review - 2026 Guidelines for ... Ischemic Stroke
1769362052,Multifocal Motor Neuropathy: ... Treatment Bibliography
1769356141,Stiff Person Syndrome: Clinical ... and Management
1769355015,Management of Dementia with Lewy Bodies, A Review
1768780482,Seronegative Autoimmune Encephalitis
1768777750,Guidelines for the Diagnosis and Clinical ... Spinal Cord
1768773618,Distinguishing Vestibular Vertigo from Posterior Stroke
1767048792,2025 In Review - MS and Autoimmune CNS Disorders
1767048620,2025 In Review - Epilepsy
1767048522,2025 In Review - Stroke and Neurovascular Disorders
1766955500,2025 In Review - Movement Disorders
1766954028,2025 In Review - Neuromuscular Disorders
1766951709,GLP-1 Receptor Agonists: ... Neurological Frontiers
1766333329,Treating psychiatric comorbidities in ... with epilepsy.
1766245202,The prognosis and treatment ... with focal epilepsy
1766244721,Global surge of early-onset Parkinson’s disease (EOPD) 
1766243879,New-onset refractory status ... syndrome (FIRES)
1765742798,Long-term outcomes of seizures ... cavernous malformations
1765742002,Phenotype-Genotype Correlations in ... (MPZ) Variants
1765640324,Cardiac Involvement in Myotonic Dystrophy Type 1 and 2
1765134925,Rituximab Therapy for Resistant Myasthenia Gravis
1764523705,Advances in Treatment of Myasthenia Gravis
1763917317,Peripheral Neuropathy: A Comprehensive Review
1763312850,Diagnostic Controversies ... Demyelinating Polyneuropathy
1763312085,Early Use of Rituximab in New-Onset ... RINOMAX Trial
1762701542,CAR-T cell therapy, neurological risks and potential use
1762111770,Active Inference Model of Functional Neurological Disorder
1762101016,Are COVID-19, RSV, and Influenza ... and effective?
1760925829,Outcome Measures for Adult Becker ... Dystrophy Progression
1760916053,2025 ILAE 2025 updated seizure classification
1760497155,Myasthenia Gravis 2025 Updated ... British Neurologists
1760495743,Iatrogenic Cerebral Amyloid ... inflammation (CAA-ri)
1759790994,Early Tirofiban After Thrombolysis for ... (ASSET-IT trial)
1759684173,Friedreich’s ataxia - A Comprehensive Look
1759678279,CADASIL Unmasked
1759078441,TTR Familial Amyloidosis Genotype-Phenotype Correlation
1758676350,Spinal Bulbar Muscular ... Practice Recommendations
1758485840,2025 Revised Criteria for Vascular Cognitive Impairment
1758484890,Idiopathic Normal Pressure Hydrocephalus: ... and Treatment
1758463162,Glycine Receptor Antibody Associated ... Outcomes (PREM)
1757879928,Neurological complications of drug misuse
1757879717,Minimally invasive surgery for intracerebral hemorrhage
1757261770,A blood test to distinguish Parkinson's ... Lewy bodies
1757260944,Navigating Postanoxic Status Epilepticus
1757258082,Migraine Prevention Review: Therapies, Efficacy, and Safety
1757168283,Using serum NFL and antibody ... autoimmune encephalitis
1757166990,Peripheral blood monocytes can predict impending ... in MS
1755442167,Late Effects of Traumatic Brain Injury
1754837241,Oseltamivir Reduces Pediatric ... During Influenza
1754098887,Health Anxiety in Neurological Settings
1753027857,Laser interstitial thermal therapy for ... lobe epilepsy
1753027046,Myasthenia Gravis Autoantibody ... Therapeutic Implications
1753026243,VCP Multisystem Proteinopathy
1752451496,Updated AAN Guidelines on prolonged ... of consciousness
1752450488,Psychiatric comorbidities are ... Autoimmune Encephalitis
1751757186,Timing of Anticoagulation for ... Atrial Fibrillation
1751756406,Treating Small Vessel CNS Vasculitis: ... and Remission
1750644367,Neurofilament Light Chain Assays in MS Management
1750283547,Nucleoside reverse transcriptase ... Alzheimer’s disease
1750020231,Lipoprotein a and Stroke Recurrence: A Systematic Review
1749419313,Serum NFL as a biomarker for CIDP Diagnosis and Treatment
1749003537,Upadacitinib for Giant-Cell Arteritis, ... Trial Results
1748811786,Assessing Functional Motor Weakness: A Practical Guide
1748811344,Treating Neuropsychiatric Symptoms in Parkinson's Disease
1748810149,Rituximab Use in Anti-NMDAR ... Relapse Prevention
1748205669,Understanding Commercial ... Neurologic Disorders
1747960787,Repeat Expansion Disorders in Neurology
1747960223,Neurological IgG4-Related Disease: Diagnosis and Management
1747959874,Long-Term Ravulizumab Efficacy and ... Myasthenia Gravis
1747005485,The Second European Carotid Surgery Trial (ECST-2)
1746495745,Inebilizumab Trial in Myasthenia Gravis
1746275173,Brain MRI as prognostic factor in Anti NMDA Encephalitis
1746220071,Efgartigimod Efficacy and Safety in CIDP ... ADHERE+ Trials
1745796325,Telitacicept Shows Strong Efficacy ... Myasthenia Gravis
1745795979,C5 vs FcRn inhibitors for generalized myasthenia gravis
1745795203,MMF for anti-NMDA antibody maintenance
1745163985,European Guidelines for Assessment ... Neurogenic Bladder
1745163610,ADVANCE CIDP -IVIG Clinical Trial
1744493887,Multifocal Motor Neuropathy - A Comprehensive Review
1744493679,Bone marrow transplantation for MS, ECTRIMS Recommendation
1744493181,Do glucose lowering drugs prevent dementia?
1743948029,Serum NfL as a Diagnostic and Prognostic ALS Biomarker
1743947883,Stress and cryptogenic stroke in young adults
1743370469,Using AI Vision in Neurology
1743279382,European Guidelines on PET imaging for brain metastasis
1743279194,Pyridostigmine for Orthostatic Hypotension
1742758256,MoCA vs MMSE for Frontotemporal Dementia
1742758097,Prognosis of Postanoxic Status Epilepticus
1742736997,Idiopathic intracranial hypertension - diagnosis
1742665488,rTMS Trial for Cognitive Impairment in ALS
1742665110,Rozanolixizumab in Generalized Myasthenia Gravis - OLE
1742138252,CSF-Serum Free Kappa Light Chain ... Neuritis Diagnosis
1742051085,ABN Guidelines on Multiple ... Disease-Modifying Treatment
1742048390,Neurological complications of immune checkpoint inhibitors
1741825944,TMPN Trial in ALS
1741825739,A Practical Approach to the Diagnosis of Neuropathies
1741539318,Therapeutics in Inflammatory Muscle Diseases
1741538675,Treatment of Cluster Headaches
1741536971,Clinical Trial of Zilucoplan in ALS
1741438800,Is Multiple Sclerosis a Virus-Induced Gliopathy?
1741137402,DDPX Antibody Associated Encephalitis - A Review
1740931031,Antidepressant use and cognitive decline ... cohort study
1740865964,Cost of New Neurologic Medications
1740864614,rTMS and Aphasia Therapy Post-Stroke, a Clinical Trial
2087965696,Periodic EEG Patterns
2087965696,Acceptance and Commitment Therapy
2087879296,Endovascular therapy versus best ... vessel occlusion
2087879296,Exenatide in Parkinson’s disease phase 3 trial 
2087879296,No long‑term benefits from resistance ... retirement age
2086669696,Tirofiban Efficacy in Stroke
2086669696,International Consensus ... Neuromuscular Complications
2086064896,Consensus Statement on Continuous EEG in ... Ill Patients
2086064896,AI-Optimized Anti-Seizure Treatment and EEG in Brain Injury
2086064896,MOG Antibody Testing in Clinical Practice
2086064896,LUMINESCE A phase 3 trial clinical ... myasthenia gravis
2086064896,Lipid Variability and Cognitive Decline in Older Adults
2086064896,Blood Biomarkers and MS Diagnosis
2086064896,Long-Term Ocrelizumab Treatment for ... Relapsing MS
2086064896,The Spectrum of Genetic Risk in Alzheimer's Disease
1737913016,Central Nervous System Manifestations in Sjögren's Disease
1737912462,Intravenous Thrombolysis for Minor ... and Meta-analysis
1737911640,Cancer risk in multiple sclerosis patients and DMT
1737911286,Neurogenic Orthostatic Hypotension in Parkinson's Disease
1737910657,Cognitive decline after heart failure
1737333009,Friedreich Ataxia: A 30-Year Retrospective
1737251959,Breaking Bad News in ALS/MND: The A-L S-PIKES Protocol
1737250775,Plasma Neurofilaments as ALS Biomarkers
1737249818,APOE's Role in Cerebral Amyloid Angiopathy
1737206633,Intra-arterial Tenecteplase After ... ATTENTION-IA trial
1736996813,WHO Classification of Central Nervous System ... to 2021
1736720954,Tele-EEG for Critically Ill Patients: A Multicenter RCT
1736600400,Ravulizumab and Efgartigimod in ... Real-World Study
1736600400,Autoimmune Nodopathies and IgG4 Antibodies in Neurology
1736600400,Anti-IgLON5 Disease: A Decade of ... Unanswered Questions
1736600400,SAHARA Trial: Transfusion ... Subarachnoid Hemorrhage
1736600400,CRISPR-Cas9 Gene Editing for ATTR Cardiomyopathy
1736091343,Introduction to Weekly Deep Dive Neurology Podcast
1736027966,Memantine in Amyotrophic Lateral Sclerosis
1736026728,Rituximab for Idiopathic Inflammatory ... and Meta-analysis
1736026371,Vutrisiran for ATTR cardiomyopathy
1736026018,Long-Term Safety of fSCIG for CIDP Maintenance Therapy
1736024204,Neurofilament Light Chain and GFAP in ... Anxiety Disorders
1736023847,Efficacy and Safety of IVIG ... Myasthenia Gravis
1736022765,Anticoagulation strategy for ... oral anticoagulant:
1735444469,Early Atogepant Efficacy in Migraine Prevention
1735441521,2024 AASM Clinical Practice Guideline: ... PLMD Treatment